We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
JHL Biotech and Affinita Biotech Agree to Partner
News

JHL Biotech and Affinita Biotech Agree to Partner

JHL Biotech and Affinita Biotech Agree to Partner
News

JHL Biotech and Affinita Biotech Agree to Partner

Read time:
 

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "JHL Biotech and Affinita Biotech Agree to Partner"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

JHL Biotech, Inc. has announced it has entered into a contract manufacturing master service agreement with Affinita Biotech. The agreement covers a development and manufacturing partnership for Affinita’s oncology monoclonal antibodies.

The agreement, extending to 2020, is estimated to be worth up to US$20 million in value. JHL will
provide cell line development, process development, and manufacturing expertise. The activities will
be carried out in JHL's Zhubei site in Taiwan as well as at JHL’s manufacturing facility in Wuhan,
China.

Advertisement